N | Proportion (%) | |
On admission | ||
Men (73.1±13.2 years):Women (79.3±13.0 years) | 1656:1653 | 50.0:50.0 |
First stroke/TIA:Recurrent stroke/TIA | 2543:766 | 76.9:23.1 |
Ischaemic stroke:Haemorrhagic stroke | 2758:518 | 83.3:15.7 |
Ischaemic stroke thrombolysis Yes:No:Not suitable | 441:2:2856 | 13.6:0.1:86.3 |
History of AF and anticoagulation and antiplatelet status | ||
History of AF:No history of AF | 666:2643 | 20.1:79.9 |
Anticoagulant treatment status of patients with AF history—Yes:No:Not suitable | 302:279:85 | 45.3:41.9:12.8 |
Antiplatelet treatment status of patients with AF history—Yes:No:Not suitable | 274:320:72 | 41.1:40.0:10.8 |
CHADS2 score in patients with history of AF | ||
0 | 30 | 4.5 |
1 | 148 | 22.2 |
2 | 200 | 30.0 |
3 | 121 | 18.2 |
4 | 125 | 18.8 |
5 | 37 | 5.6 |
6 | 5 | 0.8 |
≥2 | 488 | 73.3 |
Inpatient | ||
New AF:No previous history | 171:2643 | 6.5 |
On discharge | ||
All patients with stroke | ||
Patients with AF on discharge | 554 | 16.7 |
Anticoagulation for AF on discharge | 492 | 88.8 |
No anticoagulation for AF on discharge | 1 | 0.2 |
Anticoagulation not suitable for AF | 61 | 11.0 |
Patients with ischaemic stroke only | ||
Patients with AF on discharge | 501 | 18.2 |
No anticoagulation for AF on discharge | 1 | 0.2 |
Anticoagulation for AF on discharge | 460 | 91.8 |
Anticoagulation not suitable for AF | 40 | 8.0 |
All data were complete except a diagnosis of ischaemic or haemorrhagic stroke in 33 (1.0%) patients.
AF, atrial fibrillation; CHADS2, congestive heart failure, hypertension, age, stroke/TIA; TIA, transient ischaemic attack.